| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |